Updates

October 26, 2020October 26, 2020
Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

Using the PI3K-delta inhibitor seletalisib as an add-on to standard treatment showed a trend toward easing disease activity and dryness, and significantly lowered patient-reported ... Read more
October 19, 2020October 19, 2020
$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a part of the National Institutes of Health, has awarded a $3.7 million grant to ... Read more
October 12, 2020October 12, 2020
Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

The use of sialendoscopy, an endoscopic tool to examine and treat the salivary glands, can be used to irrigate the major salivary glands with ... Read more
September 30, 2020September 30, 2020
Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

Interleukin-38, an immune signaling molecule known as IL-38, can reduce the inflammatory activity of a type of immune cells involved in primary Sjögren’s syndrome ... Read more
September 21, 2020September 21, 2020
Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

The arginase 1 protein appears to protect from dryness symptoms associated with Sjögren’s syndrome, potentially by lowering gland inflammation and increasing fluid secretion, a new ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

May 22, 2018

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome

News

Researchers recently identified an autoantibody — an antibody produced against a person’s own tissue or molecule — significantly associated with the peripheral nerve damage common in Sjögren’s syndrome patients. This finding may help scientists understand the cause and development of ... Read more

Updates

Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

Attention Deficits May Underlie Cognitive Impairment in Neuro‐Sjögren’s, Study Finds

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

Increased Gene Activity Linked to Immune Cell Malfunction, Study Reveals

Unexplained Kidney, Neurological Problems, Fever Could Be Sjögren’s, Case Study Suggests

Saliva Levels of IL-6 Protein May Help in Diagnosing Primary Sjögren’s

Severe Dryness Symptoms Increase Risk of Cavities, Oral Candida, Study Finds

Subscribe to our mailing list

Australian Partnership to Advance Technology to Treat Sjogren’s

Luminary Therapeutics, Case Western Team Up to Develop New CAR T-Cell Therapy

Researchers Discover Two Potential Biomarkers for Primary Sjögren’s Syndrome

Bcl-6 ‘Master Regulator’ Discovery Sheds Light on Autoimmune Diseases Such as Sjogren’s

B-cell Protein May Contribute to Development of Primary Sjogren’s Syndrome, Study Suggests

Wize Completes Phase 4 Study of LO2A Eye Drops for Sjögren’s; Results Expected Later This Year

Researchers Shed Light on Genetics Behind Sex-based Vulnerability to Sjögren’s, Other Diseases

Research Implicates MicroRNA in Primary Sjögren’s Syndrome Eye Inflammation

Damage to Eye Surface Evident in Sjögren Patients, Study Reports

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Bacteria in Mouth May Trigger Inflammation Damaging to Salivary Glands

Vaginal Dryness in Sjögren’s Traced Partly to Blood Vessel Defects

Sjögren’s Symptoms Not Affected by Seasonal Changes, Study Finds

Poor Sleep Linked to Fatigue and Disease Activity in Primary Sjögren’s

Symptoms Outside Glands in Sjögren’s Patients May Increase Risk of Other Diseases

Diet Tips for Sjogren’s Syndrome Patients

Scientists Uncover Clues on How Autoimmune Diseases Develop, May Aid Diagnoses

Catalpol Improves Sjogren’s Symptoms by Affecting Immune Cell Interactions, Mouse Study Suggests

Managing Raynaud’s Phenomenon When You Have Sjogren’s

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome

Seletalisib Shows Trend Toward Easing Primary Sjögren’s in Phase 2 Trial

$3.7M NIH Grant Will Support Research to Pinpoint Genes Associated With Sjögren’s

Endoscopic Irrigation Brings Long-term Oral Relief to Sjögren’s Patients in Trial

Signaling Molecule IL-38 Can Reduce Inflammation, May Be Therapy Target, Study Finds

Arginase 1 Protein May Protect from Sjögren’s-related Dryness, Mouse Study Suggests

Attention Deficits May Underlie Cognitive Impairment in Neuro‐Sjögren’s, Study Finds

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

Increased Gene Activity Linked to Immune Cell Malfunction, Study Reveals

Unexplained Kidney, Neurological Problems, Fever Could Be Sjögren’s, Case Study Suggests

Saliva Levels of IL-6 Protein May Help in Diagnosing Primary Sjögren’s

Severe Dryness Symptoms Increase Risk of Cavities, Oral Candida, Study Finds

Subscribe to our mailing list

Australian Partnership to Advance Technology to Treat Sjogren’s

Luminary Therapeutics, Case Western Team Up to Develop New CAR T-Cell Therapy

Researchers Discover Two Potential Biomarkers for Primary Sjögren’s Syndrome

Bcl-6 ‘Master Regulator’ Discovery Sheds Light on Autoimmune Diseases Such as Sjogren’s

B-cell Protein May Contribute to Development of Primary Sjogren’s Syndrome, Study Suggests

Wize Completes Phase 4 Study of LO2A Eye Drops for Sjögren’s; Results Expected Later This Year

Researchers Shed Light on Genetics Behind Sex-based Vulnerability to Sjögren’s, Other Diseases

Research Implicates MicroRNA in Primary Sjögren’s Syndrome Eye Inflammation

Damage to Eye Surface Evident in Sjögren Patients, Study Reports

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Bacteria in Mouth May Trigger Inflammation Damaging to Salivary Glands

Vaginal Dryness in Sjögren’s Traced Partly to Blood Vessel Defects

Sjögren’s Symptoms Not Affected by Seasonal Changes, Study Finds

Poor Sleep Linked to Fatigue and Disease Activity in Primary Sjögren’s

Symptoms Outside Glands in Sjögren’s Patients May Increase Risk of Other Diseases

Diet Tips for Sjogren’s Syndrome Patients

Scientists Uncover Clues on How Autoimmune Diseases Develop, May Aid Diagnoses

Sjogren’s Patients Report Better Quality of Life Than Those With Sicca Unrelated to Disorder

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

Catalpol Improves Sjogren’s Symptoms by Affecting Immune Cell Interactions, Mouse Study Suggests

Managing Raynaud’s Phenomenon When You Have Sjogren’s